APA
Marty F. M., Ljungman P. T., Chemaly R. F., Wan H., Teal V. L., Butterton J. R., Yeh W. W., Leavitt R. Y. & Badshah C. S. (20210621). Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
Chicago
Marty Francisco M, Ljungman Per T, Chemaly Roy F, Wan Hong, Teal Valerie L, Butterton Joan R, Yeh Wendy W, Leavitt Randi Y and Badshah Cyrus S. 20210621. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
Harvard
Marty F. M., Ljungman P. T., Chemaly R. F., Wan H., Teal V. L., Butterton J. R., Yeh W. W., Leavitt R. Y. and Badshah C. S. (20210621). Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
MLA
Marty Francisco M, Ljungman Per T, Chemaly Roy F, Wan Hong, Teal Valerie L, Butterton Joan R, Yeh Wendy W, Leavitt Randi Y and Badshah Cyrus S. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. : American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 20210621.